OncoCyte Corporation (NYSE:OCX) has a beta value of 2.8 and has seen 3,987,503 shares traded in the recent trading session. The company, currently valued at $122.27 Million, closed the recent trade at $1.79 per share which meant it lost -$1.41 on the day or -43.68% during that session. The OCX stock price is -96.09% off its 52-week high price of $3.51 and 16.2% above the 52-week low of $1.5. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.47 Million shares traded. The 3-month trading volume is 447.65 Million shares.
OncoCyte Corporation (NYSE:OCX) trade information
Despite being -42.23% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Jun 25 when the OCX stock price touched $3.51-4 or saw a rise of 48.95%. Year-to-date, OncoCyte Corporation shares have moved -20.36%, while the 5-day performance has seen it change -43.29%. Over the past 30 days, the shares of OncoCyte Corporation (NYSE:OCX) have changed -35.07%. Short interest in the company has seen 1.23 Million shares shorted with days to cover at 0.
OncoCyte Corporation (OCX) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -17.4% over the past 5 years. Earnings growth for 2020 is a modest -5% while over the next 5 years, the company’s earnings are expected to increase by 0%.
OncoCyte Corporation (NYSE:OCX)’s Major holders
Insiders own 17.92% of the company shares, while shares held by institutions stand at 34.54% with a share float percentage of 42.08%. Investors are also buoyed by the number of investors in a company, with OncoCyte Corporation having a total of 84 institutions that hold shares in the company. The top two institutional holders are Broadwood Capital, Inc. with over 13.67 Million shares worth more than $33.48 Million. As of March 30, 2020, Broadwood Capital, Inc. held 20.33% of shares outstanding.
The other major institutional holder is Pura Vida Investments, LLC, with the holding of over 5.58 Million shares as of March 30, 2020. The firm’s total holdings are worth over $13.67 Million and represent 8.3% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Financial Investors Tr-Emerald Growth Fund and Vanguard Total Stock Market Index Fund. As of January 30, 2020, the former fund manager holds about 3.03% shares in the company for having 2035891 shares of worth $5.31 Million while later fund manager owns 887.16 Thousand shares of worth $2.17 Million as of March 30, 2020, which makes it owner of about 1.32% of company’s outstanding stock.